英文论文


文献类型
Article
题名
Establishment of a prediction model for disease progression within one year in newly diagnosed multiple myeloma patients
作者
Wei, Huahua; Sun, Zhihuang; Ye, Xiaoying; Yu, Jieni; Ye, Yinhai; Wang, Zifeng
作者单位
[Wei, Huahua; Ye, Xiaoying; Wang, Zifeng] Shangrao Peoples Hosp, Dept Hematol, Shangrao 334000, Jiangxi, Peoples R China. [Sun, Zhihuang] Shangrao Peoples Hosp, Dept Orthoped, Shangrao, Peoples R China. [Yu, Jieni] Zhejiang Univ, Sch Med, Shaoxing Hosp, Dept Hematol,Shaoxing Peoples Hosp, Shaoxing, Peoples R China. [Ye, Yinhai] Xiamen Univ, Affiliated Hosp 1, Dept Blood Transfus, Xiamen, Peoples R China.
通讯作者地址
Shangrao Peoples Hosp, Dept Hematol, Shangrao 334000, Jiangxi, Peoples R China.
Email
srsrmyyxyk@126.com
ResearchID
ORCID
期刊名称
HEMATOLOGY
出版社
TAYLOR & FRANCIS LTD
ISSN
1024-5332
出版信息
2022-12-31, 27 (1):575-582.
JCR
影响因子
ISBN
基金
会议名称
会议地点
会议开始日期
会议结束日期
关键词
Multiple myeloma; disease progression; predictive model; lactate dehydrogenase; Treatment of Multiple Myeloma
摘要
Purpose Multiple myeloma is still an incurable disease In the past decade, with the continuous progress of treatment methods, the progression-free survival of patients has been prolonged, but some patients still progress in the early stage of the disease. Our research analyses the clinical laboratory indicators of newly diagnosed multiple myeloma (NDMM) patients, to obtain the relevant factors of disease progression within one year in MM patients and to establish a prediction model. Methods: 108 MM patients treated in our hospital from January 2015 to January 2020 were retrospectively analyzed. After univariate and multivariate logistic regression analyses, the related factors of disease progression within one year in NDMM patients were obtained, and a prediction model was established. Results: Treatment regimen containing at least two targeted drugs (OR = 0.226, 95% CI 0.068-0.753), increased lactate dehydrogenase(LDH, OR = 3.452, 95% CI 1.101-10.826) and increased serum corrected calcium(OR = 4.466, 95% CI 1.346-14.811) were identified as potential predictors by statistical analysis. The prediction model was obtained: x = -2.042-1.489 x treatment regimen (including at least two targeted drug assignment as 1, otherwise 0) + 1.239 xLDH (U/L, lactate dehydrogenase elevation assignment as 1, normal as 0) +1.496 x serum corrected calcium (mmol/L, serum corrected calcium elevation assignment as 1, normal as 0). Receiver operating characteristic curve analysis showed that the model has good predictive performance. Conclusion: The possibility of disease progression within one year can be predicted by the prediction model. The model can be used as a reference for clinicians to make individualized treatment plans for patients so that patients can obtain better treatment effects.
一级学科
Hematology
WOS入藏号
WOS:000800393400001
EI收录号
DOI
10.1080/16078454.2022.2067940
ESI
收录于
SCIE

返回